To further validate our findings, we performed IHC and multiple immunofluorescences staining on two of the TAM markers and found that the expression of BCL2A1 was significantly correlated with CCL2 and CD68, and they were coexpressed in gliomas. The gene discussed is BCL2A1; the disease is glioma.